Post-marketing clinical study of Ogamma 100 in patients with adult T-cell leukemia (ATL)
Phase 4
- Conditions
- AT
- Registration Number
- JPRN-jRCT1080220042
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients with ATL aged between 20 and 79 years, inclusive, at time of consent
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy/safety
- Secondary Outcome Measures
Name Time Method